Home
>
US Stocks
>
Herbalife Ltd.

Herbalife Ltd. (HLF)

$11.91

+0.44

(+3.84%)▲

Market is closed - opens 7 PM, 30 May 2023

Insights on Herbalife Ltd.

  • Increasing Revenue

    Revenue is up for the last 2 quarters, 1.18B → 1.25B (in $), with an average increase of 5.7% per quarter

  • Decreasing Net Profit

    Netprofit is down for the last 5 quarters, 98.2M → 29.3M (in $), with an average decrease of 24.2% per quarter

  • Vs GIS

    In the last 1 year, General Mills, Inc. has given 20.4% return, outperforming this stock by 67.3%

  • Vs GIS

    In the last 3 years, General Mills, Inc. has given 33.5% return, outperforming this stock by 106.3%

Performance

  • $11.34
    $12.00
    $11.91
    downward going graph

    4.79%

    Downside

    Day's Volatility :5.46%

    Upside

    0.71%

    downward going graph
  • $11.14
    $30.65
    $11.91
    downward going graph

    6.47%

    Downside

    52 Weeks Volatility :63.65%

    Upside

    61.14%

    downward going graph

Returns

PeriodHerbalife Ltd.Sector (Consumer Staples)Index (Russel 2000)
3 Months
-38.45%
1.9%
-6.7%
6 Months
-31.94%
-3.0%
-3.7%
1 Year
-45.34%
-2.1%
-6.3%
3 Years
-72.83%
24.0%
26.9%

Highlights

Market Capitalization
1.1B
Book Value
- $12.39
Dividend Share
0.0
Dividend Yield
0.0%
Earnings Per Share (EPS)
2.38
PE Ratio
4.82
PEG Ratio
-32.8
Wall Street Target Price
23.67
Profit Margin
4.93%
Operating Margin TTM
9.54%
Return On Assets TTM
11.07%
Return On Equity TTM
0.0%
Revenue TTM
5.1B
Revenue Per Share TTM
52.17
Quarterly Revenue Growth YOY
-6.3%
Gross Profit TTM
2.3B
EBITDA
602.1M
Diluted Eps TTM
2.38
Quarterly Earnings Growth YOY
-0.7
EPS Estimate Current Year
2.67
EPS Estimate Next Year
3.7
EPS Estimate Current Quarter
0.65
EPS Estimate Next Quarter
0.77

Analyst Recommendation

Buy
    55%Buy
    33%Hold
    11%Sell
Based on 9 Wall street analysts offering stock ratings for Herbalife Ltd.(by analysts ranked 0 to 5 stars)
Based on 9 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
5
5
5
Hold
3
3
3
Sell
1
1
00

Analyst Forecast

What analysts predicted

Upside of 98.74%

Current $11.91
Target $23.67

Company Financials

FY17Y/Y Change
Revenue
4.4B
↓ 1.35%
Net Income
213.9M
↓ 17.73%
Net Profit Margin
4.83%
↓ 0.96%
FY18Y/Y Change
Revenue
4.9B
↑ 10.48%
Net Income
296.6M
↑ 38.66%
Net Profit Margin
6.06%
↑ 1.23%
FY19Y/Y Change
Revenue
4.9B
↓ 0.3%
Net Income
311.0M
↑ 4.86%
Net Profit Margin
6.38%
↑ 0.32%
FY20Y/Y Change
Revenue
5.5B
↑ 13.63%
Net Income
372.6M
↑ 19.81%
Net Profit Margin
6.72%
↑ 0.34%
FY21Y/Y Change
Revenue
5.8B
↑ 4.71%
Net Income
447.2M
↑ 20.02%
Net Profit Margin
7.71%
↑ 0.99%
FY22Y/Y Change
Revenue
5.2B
↓ 10.31%
Net Income
321.3M
↓ 28.15%
Net Profit Margin
6.17%
↓ 1.54%
Q4 FY21Q/Q Change
Revenue
1.3B
↓ 7.89%
Net Income
38.2M
↓ 67.46%
Net Profit Margin
2.9%
↓ 5.3%
Q1 FY22Q/Q Change
Revenue
1.3B
↑ 1.35%
Net Income
98.2M
↑ 157.07%
Net Profit Margin
7.35%
↑ 4.45%
Q2 FY22Q/Q Change
Revenue
1.4B
↑ 4.26%
Net Income
86.5M
↓ 11.91%
Net Profit Margin
6.21%
↓ 1.14%
Q3 FY22Q/Q Change
Revenue
1.3B
↓ 7.01%
Net Income
82.2M
↓ 4.97%
Net Profit Margin
6.35%
↑ 0.14%
Q4 FY22Q/Q Change
Revenue
1.2B
↓ 8.83%
Net Income
54.4M
↓ 33.82%
Net Profit Margin
4.61%
↓ 1.74%
Q1 FY23Q/Q Change
Revenue
1.3B
↑ 6.04%
Net Income
29.3M
↓ 46.14%
Net Profit Margin
2.34%
↓ 2.27%
FY17Y/Y Change
Total Assets
2.9B
↑ 12.85%
Total Liabilities
3.2B
↑ 36.33%
FY18Y/Y Change
Total Assets
2.8B
↓ 3.64%
Total Liabilities
3.5B
↑ 8.77%
FY19Y/Y Change
Total Assets
2.7B
↓ 3.99%
Total Liabilities
3.1B
↓ 12.66%
FY20Y/Y Change
Total Assets
3.1B
↑ 14.84%
Total Liabilities
3.9B
↑ 28.14%
FY21Y/Y Change
Total Assets
2.8B
↓ 8.33%
Total Liabilities
4.2B
↑ 7.1%
FY22Y/Y Change
Total Assets
2.7B
↓ 3.11%
Total Liabilities
4.0B
↓ 5.07%
Q4 FY21Q/Q Change
Total Assets
2.8B
↓ 1.16%
Total Liabilities
4.2B
↑ 0.59%
Q1 FY22Q/Q Change
Total Assets
2.8B
↑ 0.17%
Total Liabilities
4.3B
↑ 1.58%
Q2 FY22Q/Q Change
Total Assets
2.8B
↓ 0.79%
Total Liabilities
4.2B
↓ 1.4%
Q3 FY22Q/Q Change
Total Assets
2.7B
↓ 2.76%
Total Liabilities
4.1B
↓ 3.1%
Q4 FY22Q/Q Change
Total Assets
2.7B
↑ 0.25%
Total Liabilities
4.0B
↓ 2.18%
Q1 FY23Q/Q Change
Total Assets
2.7B
↓ 1.63%
Total Liabilities
3.9B
↓ 2.19%
FY17Y/Y Change
Operating Cash Flow
590.8M
↑ 60.85%
Investing Cash Flow
-97.8M
↓ 30.79%
Financing Cash Flow
-85.2M
↓ 66.23%
FY18Y/Y Change
Operating Cash Flow
648.4M
↑ 9.75%
Investing Cash Flow
-83.9M
↓ 14.21%
Financing Cash Flow
-593.1M
↑ 596.13%
FY19Y/Y Change
Operating Cash Flow
457.5M
↓ 29.44%
Investing Cash Flow
-108.0M
↑ 28.72%
Financing Cash Flow
-713.0M
↑ 20.22%
FY20Y/Y Change
Operating Cash Flow
628.6M
↑ 37.4%
Investing Cash Flow
-123.2M
↑ 14.07%
Financing Cash Flow
-320.9M
↓ 54.99%
FY21Y/Y Change
Operating Cash Flow
460.3M
↓ 26.77%
Investing Cash Flow
-156.4M
↑ 26.95%
Financing Cash Flow
-728.6M
↑ 127.05%
Q4 FY21Q/Q Change
Operating Cash Flow
85.4M
↓ 2.95%
Investing Cash Flow
-47.5M
↑ 17.28%
Financing Cash Flow
-108.6M
↓ 45.75%
Q1 FY22Q/Q Change
Operating Cash Flow
130.5M
↑ 52.81%
Investing Cash Flow
-41.2M
↓ 13.26%
Financing Cash Flow
-122.4M
↑ 12.71%
Q2 FY22Q/Q Change
Operating Cash Flow
98.8M
↓ 24.29%
Investing Cash Flow
-34.6M
↓ 16.02%
Financing Cash Flow
-36.6M
↓ 70.1%
Q3 FY22Q/Q Change
Operating Cash Flow
69.6M
↓ 29.55%
Investing Cash Flow
-113.4M
↑ 227.75%
Financing Cash Flow
-56.2M
↑ 53.55%
Q1 FY23Q/Q Change
Operating Cash Flow
46.2M
↓ 13.81%
Investing Cash Flow
-30.2M
-
Financing Cash Flow
-76.0M
↑ 53.54%

Technicals Summary

Sell

Neutral

Buy

Herbalife Ltd. is currently in a neutral trading position according to technical analysis indicators.

More on Technical Analysis

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Herbalife Ltd.
Herbalife Ltd.
-20.81%
-31.94%
-45.34%
-72.83%
-75.72%
Kraft Heinz Company, The
Kraft Heinz Company, The
-3.42%
-1.64%
1.51%
26.03%
-33.1%
McCormick & Company, Incorporated
McCormick & Company, Incorporated
-1.67%
3.8%
-6.24%
-0.74%
68.88%
Hormel Foods Corporation
Hormel Foods Corporation
-5.32%
-20.17%
-20.96%
-21.22%
5.37%
General Mills, Inc.
General Mills, Inc.
-5.81%
1.62%
20.52%
33.53%
98.16%
Kellogg Co.
Kellogg Co.
-4.41%
-6.53%
-2.97%
3.61%
4.78%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Herbalife Ltd.
Herbalife Ltd.
4.82
4.82
-32.8
2.67
0.0
0.11
0.0
-12.39
Kraft Heinz Company, The
Kraft Heinz Company, The
19.51
19.51
2.89
2.69
0.05
0.03
0.04
40.06
McCormick & Company, Incorporated
McCormick & Company, Incorporated
35.31
35.31
6.13
2.63
0.14
0.04
0.02
18.16
Hormel Foods Corporation
Hormel Foods Corporation
21.48
21.48
3.33
1.72
0.13
0.06
0.03
13.93
General Mills, Inc.
General Mills, Inc.
18.18
18.18
3.11
4.24
0.27
0.07
0.03
17.39
Kellogg Co.
Kellogg Co.
23.72
23.72
2.99
4.11
21.31
0.05
0.03
11.82
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Herbalife Ltd.
Herbalife Ltd.
Buy
$1.1B
-75.72%
4.82
4.93%
Kraft Heinz Company, The
Kraft Heinz Company, The
Hold
$46.9B
-33.1%
19.51
9.0%
McCormick & Company, Incorporated
McCormick & Company, Incorporated
Sell
$23.4B
68.88%
35.31
10.42%
Hormel Foods Corporation
Hormel Foods Corporation
Hold
$20.9B
5.37%
21.48
7.9%
General Mills, Inc.
General Mills, Inc.
Hold
$49.4B
98.16%
18.18
14.04%
Kellogg Co.
Kellogg Co.
Hold
$23.3B
4.78%
23.72
5.33%

Institutional Holdings

  • Vanguard Group Inc

    12.44%

  • Route One Investment Co, LP

    10.96%

  • WINDACRE PARTNERSHIP LLC

    9.35%

  • BlackRock Inc

    7.37%

  • Renaissance Technologies Corp

    7.04%

  • Morgan Stanley - Brokerage Accounts

    5.52%

Company Information

Herbalife Nutrition is a global company that has been changing people's lives with great nutrition products and a proven business opportunity for its independent distributors since 1980. The Company offers high-quality, science-backed products, sold in over 90 countries by entrepreneurial distributors who provide one-on-one coaching and a supportive community that inspires their customers to embrace a healthier, more active lifestyle. Through the Company's global campaign to eradicate hunger, Herbalife Nutrition is also committed to bringing nutrition and education to communities around the world.

Organization
Herbalife Ltd.
Employees
10100
CEO
Mr. John G. DeSimone
Industry
Medical Distributors

Discover More

FAQs